A carregar...
Optimizing Surgical and Imatinib Therapy for the Treatment of Gastrointestinal Stromal Tumors
INTRODUCTION: The discovery of activating KIT and PDGFRα mutations in gastrointestinal stromal tumors (GISTs) represented a milestone as it allowed clinicians to use tyrosine kinase inhibitors, like imatinib, to treat this sarcoma. Although surgery remains the only potentially curative treatment, pa...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer US
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3824223/ https://ncbi.nlm.nih.gov/pubmed/23775094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11605-013-2243-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|